Useful Reading

The Insanity of Prescription Drug Prices in America

Television advertising of prescription drugs is one of the main drivers of soaring prices.

The Coronavirus Pandemic Hasn’t Stopped Drug Price Increases

Pharmaceutical companies raised the price of 245 drugs between January 20 and June 20, according to a new analysis by Patients for Affordable Drugs.

State Attorneys General Sue Generic Drugmakers for Inflating Prices

A coalition of 51 state and local attorneys general, including those of New York and New Jersey, filed a lawsuit Wednesday accusing 26 drug companies of conspiring to artificially inflate prices of 80 topical generic drugs.

Trump’s $35 Insulin Plan: A Nickel Solution to a Billion-Dollar Problem

On first blush, President Donald Trump’s $35 insulin discount policy may seem like a serious attack on high prescription drug prices.

Yes, the Government Can Control the Cost of a Coronavirus Vaccine

The claim that the U.S. government has no control over drug prices is, simply put, a lie.

In U.S., 66% Report Increase in Cost of Prescription Drugs

Two-thirds of U.S. adults report that prescription drug prices have increased either a little or a lot since 2017, the first year of the Trump administration. Self-identified Democrats and independents are more likely to perceive an increase in prices than Republicans.

Brand-name Prescription Drug Prices Have Spiked Since 2007

The price of brand-name prescription drugs went up by 60% between 2007 and 2018, after accounting for rebates and discounts, according to a new study in JAMA.

Americans are Skipping Medically Necessary Prescriptions because of the Cost

For many Americans, the cost of regularly taking and filling their medications is too much.

Kaiser Health News: Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?

Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, with voters from both parties agreeing that reducing the cost of prescription drugs should be one of Congress’ top priorities.

Las Vegas SUN:
Horsford: Prescription Drug Affordability Not a Partisan Issue

Some of the bills Rep. Steve Horsford and other Democrats have backed — including measures to expand access to dental care and cap prescription drug costs — are headed to the House floor after passing through committee mark-up last week.

List Prices for Medicare Part D Drugs Exceeded Inflation in 2016, 2017, Analysis Says

List price increases for many Medicare Part D drugs—both brands and generics—exceeded inflation in 2016 and 2017, in some cases by a substantial margin, according to a recent analysis from the Kaiser Family Foundation.

Report: Prescription Drug Prices Climb Nearly 26% in 3 Years

Drug pricing transparency has long been an area of focus for consumers and policymakers, with numerous studies highlighting the inequity in drug spending across various disease states as well as a recent substantial rise in out-of-pocket costs.

Can Washington Deliver on Drug Costs Amid Impeachment Probe?

Major legislation to reduce prescription drug costs for millions of people may get sidelined now that House Democrats have begun an impeachment inquiry of President Donald Trump.

Wall Street Journal: Drugmakers, Worried About Losing Pricing Power, Are Lobbying Hard

Pharmaceutical industry attacks proposals in Washington that could cut deeply into companies’ sales.

Bloomberg: Why Millions of Senior Citizens Can’t Get Needed Medications

A new watchdog report says prescriptions are being rejected because doctors and insurers don’t communicate with each other.

Axios: Generic Prescription Drugs are Sometimes Inaccessible to Seniors

Plans providing Medicare’s prescription drug benefit are often slow to cover the first generic competition to a branded medication, according to a new white paper by the Association for Accessible Medicines.

Public’s View of Drug Companies Sinks to Record Low in Gallup Poll

The public’s favorability toward the pharmaceutical industry is at its lowest point since Gallup began polling the question in 2001.

Congress Must Act Now to Pave Way for More Affordable Prescription Drugs

The out-of-pocket costs required to successfully manage [chronic] conditions are forcing many patients to abandon treatments or forego other necessities such as food, shelter or transportation costs. Although biosimilar medications hold great promise for decreasing health care costs, congressional action is needed to increase competition for biosimilars and unlock their cost-savings potential.

Medicare Must Be Allowed to Negotiate Drug Prices

Four influential Democratic Senators delivered a message to their Republican colleagues and President Trump today:  allowing Medicare to negotiate directly with Big Pharma is the best way to bring down prescription drug prices.